Effects of candesartan cilexetil on glucose homeostasis

Basic Research in Cardiology

Volumn 93, Issue 2 SUPPL., 1998, Pages 140-144

  Trenkwalder, P ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiotensin receptor blockers; Candesartan cilexetil; Diabetes mellitus; Glucose homeostasis; Serum lipids

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; BORDERLINE HYPERTENSION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEADACHE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TRIACYLGLYCEROL BLOOD LEVEL; VERTIGO;

AGED; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; PRODRUGS; TETRAZOLES; TREATMENT OUTCOME;

EID: 0031736531     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s003950050241     Document Type: Article

References (19)

1. Chow L, De Gasparo M, Levens N (1995) Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors. Europ J Pharmacol 282: 77-86
2. Delacrétaz E, Nussberger J, Biollaz J, Waeber B, Brunner HR (1995) Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers. Hypertension 25: 14-21
3. Ferrari P, Rosman J, Weidmann P (1991) Antihypertensive agents, serum lipoproteins and glucose metabolism. Am J Cardiol 67: 26B-35B
4. Goa KL, Wagstaff AJ (1996) Losartan potassium: A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs 51: 820-845
5. Herings RM, de Boer A, Stricker BH, Leufkens HG, Porsius A (1995) Hypoglyeaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet 345: 1195-1198
6. Iimura O, Shimamoto K, Matsuda K (1995) Effects of angiotensin receptor antagonists and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. Am J Hypertens 8: 353-357
7. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1993) The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 153: 154-183
8. Kannel WB (1992) Potency of vascular risk factors as a basis for antihypertensive therapy. Europ Heart J 13 (suppl G): 34-42 (Pubitemid 23077953)
9. Kaplan NM (1995) Combination therapy for systemic hypertension. Am J Cardiol 76: 595-597
10. Laakso M, Karjalainen L, Lempiäinen- Kuosa P (1996) Effects of losartan on insulin sensitivity in hypertensive subjects. Hypertension 28: 392-396 (Pubitemid 26296040)
11. Lithell HOL (1991) Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 134: 203-209
12. Madu EC, Reddy RC, Madu AN, Anyaogu C, Harris T, Fraker TD Jr (1996) Review: The effects of antihypertensive agents on serum lipids. Am J Med Sci 312 (2): 76-84 (Pubitemid 26275298)
13. Messerli FH, Weber MA, Brunner HR (1996) Angiotensin II receptor inhibition. A new therapeutic principle. Arch Intern Med 156: 1957-1965 (Pubitemid 26318103)
14. Middeke M, Holzgreve H (1988) Review of major intervention studies in hypertension and hyperlipidemia: Focus on coronary heart disease. Am Heart J 116: 1708-1712 (Pubitemid 19015650)
15. Moan A, Risanger T, Eide I (1994) The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension. Blood Press 3: 185-188 (Pubitemid 24169150)
16. Ojima M, Inada Y, Shibouta Y, Wada T, Sanada T, Kubo K, Nishikawa K (1997) Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor. Europ J Pharmacol 319: 137-146 (Pubitemid 27051327)
17. Rett K, Wicklmayr M, Dietze G, Mehnert H (1989) Clinical studies with ACE-inhibitors in diabetes. Horm Metab Res 22 (suppl): 69-74
18. Weber MA, Byyny RL, Pratt H, Faison EP, Snavely DB, Goldberg AI, Nelson EB (1995) Blood pressure effects of the angiotensin II receptor blocker, losartan. Arch Intern Med 155: 405-411
19. Working Group on Management of Patients with Hypertension and High Blood Cholesterol (1991) National Education Programs Working Group Report on the Management of Patients with Hypertension and High Blood Pressure. Ann Intern Med 114: 224-237